Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Biomedicines|January 28, 2026
RXR Agonist V-125 Induces Distinct Transcriptional and Immunomodulatory Programs in Mammary Tumors of MMTV-Neu Mice Compared to BexaroteneAfrin Sultana Chowdhury, Lyndsey A Reich, Karen T Liby, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
A CAMKK2-UBR4-19S Proteasome Axis Regulates Chondrocyte Proteostasis and SOX9 StabilityXinchun Ding, Yong Li, Kasi Hansen, et al.
International Journal of Molecular Sciences|November 23, 2019
HUNK Phosphorylates Rubicon to Support AutophagyJoelle N Zambrano, Scott T Eblen, Melissa Abt, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2013
Hunk negatively regulates c-myc to promote Akt-mediated cell survival and mammary tumorigenesis induced by loss of PtenElizabeth S Yeh, George K Belka, Ann E Vernon, et al.
The Journal of Clinical Investigation|March 12, 2011
Hunk is required for HER2/neu-induced mammary tumorigenesisElizabeth S Yeh, Thomas W Yang, Jason J Jung, et al.
Oncotarget|January 10, 2018
Dysregulated connexin 43 in HER2-positive drug resistant breast cancer cells enhances proliferation and migrationElizabeth S Yeh, Christina J Williams, Carly Bess Williams, et al.
Biomedicines|December 16, 2020
NF-κB Signaling Is Regulated by Fucosylation in Metastatic Breast Cancer CellsEmma H Doud, Trupti Shetty, Melissa Abt, et al.
BMC Cancer|April 17, 2015
Targeting connexin 43 with α-connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1Christina L Grek, Joshua Matthew Rhett, Jaclynn S Bruce, et al.
Discover Education|December 1, 2025
Hands-on summer research programs at Indiana university Simon comprehensive cancer centerElizabeth S Yeh, Shannon M Hawkins, Jessica Byram, et al.
Cell Chemical Biology|February 2, 2024
Identification and characterization of a potent and selective HUNK inhibitor for treatment of HER2+ breast cancerTinslee Dilday, Melissa Abt, Nicole Ramos-Solís, et al.
Pageof 4